Animal Drugs, Feeds, and Related Products; Selegiline Hydrochloride Tablet
other · Food and Drug Administration · Rule · Published 1997-06-27 · Effective 1997-06-27 · 62 FR 34631
Document
Document number
97-16791
Federal Register citation
62 FR 34631
CFR reference
21 CFR 510
Type
Rule
Action
Final rule.
Category
other
Sub-agency
Food and Drug Administration
Publication date
1997-06-27
Effective date
1997-06-27
Abstract
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a new animal drug application (NADA) filed by Deprenyl Animal Health, Inc. The NADA provides for oral use of selegiline hydrochloride tablets for dogs for the control of clinical signs associated with uncomplicated pituitary-dependent hyperadrenocorticism.